Key industry trends and how the relationships between companies and CDMOs are evolving to better meet the challenges of a BANI world.
Jimmy Wei, PhD
Advertisement
President, Chime Biologics
Articles by Jimmy Wei, PhD
Advertisement
Latest Updated Articles
CDMOs are Exploring Risk-Sharing for Resilient Growth in a BANI WorldPublished: August 23rd 2024 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
TrumpRx and the Dawn of Direct-to-Consumer Commercialization
2
FDA Approves Bayer’s Lynkuet as First Dual Neurokinin Antagonist for Menopausal Hot Flashes
3
FDA Approves Blenrep for Treatment of Replapsed/Refractory Multiple Myeloma
4
Lilly Enters Definitive Agreement Acquiring Aderum Biotechnologies
5
